Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ergotamine tartrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Migril tablets
0407041F0BGAAAJ
|
Migril | Ergotamine tartrate | Central Nervous System | 59 |
|
Ergotamine 1mg / Caffeine 100mg tablets
0407041F0AAAMAM
|
Ergotamine tartrate | Ergotamine tartrate | Central Nervous System | 1 |
|
Cafergot suppositories
0407041F0BFAAAH
|
Cafergot | Ergotamine tartrate | Central Nervous System | No data available |
|
Cafergot tablets
0407041F0BFABAM
|
Cafergot | Ergotamine tartrate | Central Nervous System | No data available |
|
Ergotamine tartrate 2mg / Caffeine 100mg suppositories
0407041F0AAAHAH
|
Ergotamine tartrate | Ergotamine tartrate | Central Nervous System | No data available |
|
Generic Migril tablets
0407041F0AAAJAJ
|
Ergotamine tartrate | Ergotamine tartrate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.